References
Gottschlich S, Röschmann K, Candler H. Phytomedicines in acute rhinosinusitis: a prospective, non-interventional parallel-group trial. Adv Ther. 2018;35:1023–34.
Tesche S, Metternich F, Sonnemann U, Engelke JC, Dethlefsen U. The value of herbal medicines in the treatment of acute non-purulent rhinosinusitis. Results of a double-blind, randomised, controlled trial. Eur Arch Otorhinolaryngol. 2008;265:1355–9.
Jund R, Mondigler M, Stammer H, Stierna P, Bachert C. Herbal drug BNO 1016 is safe and effective in the treatment of acute viral rhinosinusitis. Acta Otolaryngol. 2015;135:42–50.
Palm J, Steiner I, Abramov-Sommariva D, et al. Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis. Rhinology. 2017;55:142–51.
Passali D, Loglisci M, Passali GC, Cassano P, Rodriguez HA, Bellussi LM. A prospective open-label study to assess the efficacy and safety of a herbal medicinal product (Sinupret) in patients with acute rhinosinusitis. J Otorhinolaryngol Relat Spec. 2015;77:27–32.
Kreindler JL, Chen B, Kreitman Y, Kofonow J, Adams KM, Cohen NA. The novel dry extract BNO 1011 stimulates chloride transport and ciliary beat frequency in human respiratory epithelial cultures. Am J Rhinol Allergy. 2012;26:439–43.
World Health Organization. WHO traditional medicine strategy 2002–2005. http://www.wpro.who.int/health_technology/book_who_traditional_medicine_strategy_2002_2005.pdf. Accessed 23 Oct 2018.
Wegener T. Patterns and trends in the use of herbal products, herbal medicine and herbal medicinal products. Int J Complement Alt Med. 2017;9:00317.
Acknowledgements
Funding
No funding or sponsorship was received for this study or publication of this article.
Medical Writing and/or Editorial Assistance
Medical writing support was provided by Jamie Thurman-Newell, PhD of Synergy Vision (United Kingdom) and funded by Bionorica SE.
Authorship
All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work as a whole, and have given their approval for this version to be published.
Disclosures
Prof Dr. Dr. h.c. mult. Claus Bachert is affiliated with the Head Upper Airways Research Laboratory (URL), University Hospital Gent, Belgium. Dr. Mayank Thakur is affiliated with Bionorica SE, Kerschensteinerstr. 11–15, 92318 Neumarkt, Germany. Simon Weyers is affiliated with Bionorica SE, Kerschensteinerstr. 11–15, 92318 Neumarkt, Germany. Dr. Claudia Bittner is affiliated with Bionorica SE, Kerschensteinerstr. 11–15, 92318 Neumarkt, Germany. Dimitri Abramov-Sommariva (MD) is affiliated with Bionorica SE, Kerschensteinerstr. 11–15, 92318 Neumarkt, Germany.
Compliance with Ethics Guidelines
This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bachert, C., Thakur, M., Weyers, S. et al. Reporting Clinical Trial Results of Phytomedicines in Acute Rhinosinusitis: Letter to the Editor Regarding Gottschlich S, Röschmann K, Candler H. Adv Ther (2018); 35:1023–1034. doi: 10.1007/s12325-018-0736-7. Adv Ther 36, 1011–1013 (2019). https://doi.org/10.1007/s12325-019-00933-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-019-00933-6